Our keynote sessions set the tone for the congress, bringing together senior leaders from across BioPharma R&D and Manufacturing to share their vision for the future of scientific innovation and operational transformation. These talks explore the strategies and roadmaps driving change, highlighting the technological, organisational, and cultural shifts needed to adopt emerging technologies, scale innovation, and deliver the next generation of scientific breakthroughs.
“Foundations for AI-Driven R&D”
Scaling AI and agentic systems across R&D requires more than new technology. Success depends on a clear digital strategy, robust data foundations and connected laboratory infrastructure. This session will explore how these capabilities are reshaping the way research is conducted, decisions are made and innovation is delivered. Speakers will examine both the foundations required to enable AI at scale and its practical application in accelerating scientific discovery, optimising R&D workflows and improving decision-making.
“Connecting Every Step of the Scientific Workflow”
As laboratory environments evolve there is an increasing focus on building a fully connected lab ecosystem, where workflows, data, robotics, and software platforms function together as one coordinated system. In this session speakers will discuss how they are capturing and contextualizing data, automating Laboratory workflows and implementing digital frameworks and platforms that enable connectivity.
Digital CMC“The Next Generation of CMC”
Building on the conference themes of AI, data, digitalisation and connected labs this track will focus on their application across the CMC landscape. Sessions will explore how organisations are transforming development, manufacturing, quality, and regulatory operations through digital technologies, connected data, automation, and intelligent systems. Speakers will share how they are building the digital infrastructure and data foundations needed to enable AI in CMC, modernise operations and create more connected, efficient, and resilient organisations.
“Reshaping the Future of R&D”
Hear from a carefully selected group of biotechs, pharmaceutical companies, startups, and technology innovators that are challenging conventional approaches to R&D. In this fast-paced new format, organisations will showcase breakthrough technologies, novel approaches, and bold ideas that have the potential to reshape the future of R&D.